NO PBMs Act

Bill 118 hr 5400, also known as the NO PBMs Act, is a piece of legislation introduced in the US Congress aimed at addressing issues related to pharmacy benefit managers (PBMs). PBMs are third-party administrators that manage prescription drug benefits for health insurance plans.

The main goal of the NO PBMs Act is to increase transparency and accountability within the PBM industry. The bill seeks to achieve this by requiring PBMs to disclose information about their pricing practices, rebates, and discounts they receive from drug manufacturers. This information would then be made available to the public and to the Department of Health and Human Services.

Additionally, the bill aims to address concerns about PBMs engaging in anti-competitive practices that may drive up drug prices for consumers. The NO PBMs Act includes provisions that would prohibit PBMs from engaging in certain practices, such as steering patients to certain pharmacies or drugs in order to maximize profits. Overall, the NO PBMs Act is intended to promote greater transparency and competition within the PBM industry, with the ultimate goal of lowering prescription drug costs for consumers. The bill has garnered bipartisan support in Congress and is currently being considered in committee for further review and potential amendments before being brought to a vote.